Get the Stockscreener App
144.55
0.42%
0.76
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Merck Co Inc stock is traded at $144.55, with a volume of 2.88M.
It is up +0.42% in the last 24 hours and up +6.30% over the past month.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
See More
Previous Close:
$143.79
Open:
$143.96
24h Volume:
2.88M
Relative Volume:
0.28
Market Cap:
$356.72B
Revenue:
$65.51B
Net Income/Loss:
$8.93B
P/E Ratio:
40.68
EPS:
3.5532
Net Cash Flow:
$14.12B
1W Performance:
-2.12%
1M Performance:
+6.30%
6M Performance:
+25.10%
1Y Performance:
+78.07%
1-Day Range:
$143.50
$144.71
1-Week Range:
$142.32
$148.00
52-Week Range:
$77.58
$156.92
Merck Co Inc Stock (MRK) Company Profile
Name
Merck Co Inc
Sector
Industry
Phone
908-740-4000
Address
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, NVS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
144.59 | 355.10B | 65.51B | 8.93B | 14.12B | 3.5532 |
LLY
Lilly Eli Co
|
1,139.73 | 994.49B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
268.62 | 640.02B | 97.93B | 21.04B | 17.80B | 8.6278 |
ABBV
Abbvie Inc
|
263.93 | 454.36B | 62.82B | 3.60B | 19.98B | 2.0274 |
NVS
Novartis Ag Adr
|
139.18 | 260.70B | 54.66B | 13.58B | 16.05B | 7.0171 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-25-26 | Initiated | RBC Capital Mkts | Outperform |
| Feb-20-26 | Initiated | Barclays | Overweight |
| Feb-13-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-08-26 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-18-25 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Nov-24-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-13-25 | Initiated | Scotiabank | Sector Outperform |
| Oct-13-25 | Resumed | Citigroup | Neutral |
| Sep-17-25 | Downgrade | Berenberg | Buy → Hold |
| May-14-25 | Downgrade | Citigroup | Buy → Neutral |
| Apr-22-25 | Initiated | Cantor Fitzgerald | Neutral |
| Feb-18-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-10-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-08-25 | Downgrade | Truist | Buy → Hold |
| Dec-20-24 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-10-24 | Resumed | BofA Securities | Buy |
| Dec-04-24 | Upgrade | HSBC Securities | Hold → Buy |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-11-24 | Downgrade | Daiwa Securities | Buy → Neutral |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Mar-11-24 | Downgrade | Societe Generale | Hold → Sell |
| Jan-04-24 | Upgrade | TD Cowen | Market Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Buy |
| Oct-27-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Oct-20-23 | Upgrade | UBS | Neutral → Buy |
| Jul-14-23 | Initiated | HSBC Securities | Hold |
| Apr-13-23 | Upgrade | Citigroup | Neutral → Buy |
| Mar-28-23 | Downgrade | Societe Generale | Buy → Hold |
| Mar-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-06-23 | Initiated | Jefferies | Buy |
| Feb-22-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-04-23 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| Oct-10-22 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-14-22 | Upgrade | Berenberg | Hold → Buy |
| Jul-06-22 | Upgrade | Daiwa Securities | Neutral → Buy |
| Jun-06-22 | Resumed | SVB Leerink | Outperform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Dec-17-21 | Initiated | Goldman | Buy |
| Dec-16-21 | Initiated | Daiwa Securities | Neutral |
| Dec-13-21 | Downgrade | UBS | Buy → Neutral |
| Dec-09-21 | Initiated | Wells Fargo | Overweight |
| Dec-07-21 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-29-21 | Downgrade | Citigroup | Buy → Neutral |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Nov-01-21 | Upgrade | Argus | Hold → Buy |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-27-21 | Resumed | Truist | Buy |
| May-20-21 | Downgrade | Argus | Buy → Hold |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Nov-10-20 | Resumed | Bernstein | Outperform |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Aug-03-20 | Upgrade | Goldman | Neutral → Buy |
| Jun-12-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Jan-07-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-16-19 | Initiated | SVB Leerink | Outperform |
| Jul-03-19 | Initiated | Mizuho | Buy |
| May-28-19 | Initiated | Goldman | Neutral |
| May-13-19 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-16-18 | Reiterated | Citigroup | Buy |
| Oct-09-18 | Resumed | Guggenheim | Buy |
| Apr-23-18 | Upgrade | Goldman | Neutral → Buy |
| Apr-17-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-05-18 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-12-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Feb-14-18 | Reiterated | Leerink Partners | Mkt Perform |
| Feb-07-18 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-16-18 | Upgrade | SunTrust | Hold → Buy |
View All
Merck Co Inc Stock (MRK) Latest News
Merck & Co. stock gains as DBS lifts price target and Q2 2026 revenue grows - ad-hoc-news.de
Merck & Co. stock holds after Wall Street Zen cuts rating - ad-hoc-news.de
Merck & Co., Inc. (NYSE:MRK) Lowered to Hold Rating by Wall Street Zen - MarketBeat
7,741 Shares in Merck & Co., Inc. $MRK Bought by Talon Private Wealth LLC - MarketBeat
Merck & Co. stock gains as analysts lift price targets on cancer drug progress - ad-hoc-news.de
The Manufacturers Life Insurance Company Has $266.40 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
IPG Investment Advisors LLC Lowers Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Corient Private Wealth LP - MarketBeat
Rep. Maria Elvira Salazar Buys Merck & Co., Inc. (NYSE:MRK) Stock - MarketBeat
Merck & Co. stock heads into the open after a 1.9% drop - ad-hoc-news.de
Merck & Co., Inc. (NYSE:MRK) Trading Down 1.9%Should You Sell? - MarketBeat
Merck (MRK) Dips More Than Broader Market: What You Should Know - Yahoo Finance
GSK's Specialty Medicines Drive Growth Amid Looming HIV Patent Cliff - Zacks Investment Research
Recent Filing Shows That Rep. Maria Elvira Salazar Bought Over $34K Worth of Merck & Co Stock - Benzinga
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $172.00 - MarketBeat
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Here's Why We're Wary Of Buying Merck's (NYSE:MRK) For Its Upcoming Dividend - simplywall.st
National Pension Service Raises Stake in Merck & Co., Inc. $MRK - MarketBeat
Integrated Wealth Concepts LLC Acquires 13,850 Shares of Merck & Co., Inc. $MRK - MarketBeat
11,499 Shares in Merck & Co., Inc. $MRK Bought by Blue Edge Capital LLC - MarketBeat
Archford Capital Strategies LLC Has $3.52 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co. stock heads into the open after a flat Nasdaq close - ad-hoc-news.de
Merck & Co., Inc. (NYSE:MRK) Given New $161.00 Price Target at Leerink Partners - MarketBeat
Merck & Co. stock gains as Guggenheim raises price target on oncology optimism - ad-hoc-news.de
NewEdge Advisors LLC Purchases 41,950 Shares of Merck & Co., Inc. $MRK - MarketBeat
Baird Financial Group Inc. Sells 98,410 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Ameritas Advisory Services LLC - MarketBeat
Merck & Co. stock heads into the open after a 1.0 percent drop - AD HOC NEWS
Allworth Financial LP Decreases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co. Inc. stock outperforms competitors despite losses on the day - MarketWatch
Merck & Co., Inc. (NYSE:MRK) Stock Price Expected to Rise, Guggenheim Analyst Says - MarketBeat
Merck Trading Near 52-Week High: Is the Stock a Buy, Hold or Sell? - TradingView
Merck Animal Health Supports Next Generation of Bovine Veterinarians with $90,000 in Scholarships - American Ag Network
Guggenheim Adjusts Price Target on Merck & Co. to $170 From $146, Maintains Buy Rating - Moomoo
Merck's CEO and research chief will speak online Sept. 14 - Stock Titan
Merck to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - Business Wire
The Hashgraph Group, Merck, and PwC Germany Develop Solution for Cocoa Traceability and Digital Product Passports - marketscreener.com
Merck & Co. stock gains on Wells Fargo price target hike and cancer vaccine momentum - AD HOC NEWS
Weekly Recap: Intismeran win and Personalis 13% stake backs Tempus AI - tradingview.com
VIRGINIA RETIREMENT SYSTEMS ET Al Invests $79.56 Million in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (MRK) Stock Analysis: Navigating a Healthcare Giant with a $370 Billion Market Cap - DirectorsTalk Interviews
California State Teachers Retirement System Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Amundi Has $1.59 Billion Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Saudi Central Bank - MarketBeat
NBH Bank Takes Position in Merck & Co., Inc. $MRK - MarketBeat
Old Mission Investment Co LLC Makes New $1.34 Million Investment in Merck & Co., Inc. $MRK - MarketBeat
Oakmont Investment Advisors Inc. Invests $3.10 Million in Merck & Co., Inc. $MRK - MarketBeat
Three Seasons Wealth LLC Raises Stake in Merck & Co., Inc. $MRK - MarketBeat
Maloon Powers Pitre Higgins & Dennehy LLC Invests $882,000 in Merck & Co., Inc. $MRK - marketbeat.com
Merck & Co. Inc. stock underperforms Friday when compared to competitors - MarketWatch
Merck Co Inc Stock (MRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
1.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):